You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 51 No. 8, August 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cerebellar Atrophy in Patients With Long-term Phenytoin Exposure and Epilepsy

Gershon C. Ney, MD; George Lantos, MD; William B. Barr, PhD; Neil Schaul, MD

Arch Neurol. 1994;51(8):767-771.


Abstract

Objective
Cerebellar atrophy has been noted in patients with phenytoin exposure. This finding has been attributed by some investigators to seizures, but by others to phenytoin. Previous studies included patients with mental retardation and convulsive seizures. We undertook a study in a group of nonretarded patients with partial epilepsy to better elucidate the cause of the cerebellar atrophy.

Design
Case control study.

Setting
Referral population from an epilepsy center.

Patients
Thirty-six patients with partial epilepsy and long-term phenytoin exposure were selected from a consecutive sample of admissions to an epilepsy center. Patients with histories of ethanol abuse, perinatal distress, anoxia, status epilepticus, or neurodegenerative disorders were excluded. Age- and sex-matched controls were selected from a pool of healthy volunteers and patients who had undergone magnetic resonance imaging for complaints of headache and dizziness.

Interventions
All patients and controls underwent magnetic resonance imaging.

Main Outcome Measure
Degree of cerebellar atrophy.

Results
The magnetic resonance imaging scans were reviewed in a blind fashion. A rating was assigned to each scan based on the degree of cerebellar atrophy. Cerebellar atrophy was significantly more pronounced in patients than in controls. No correlation was found between cerebellar atrophy and variables reflective of seizure severity or degree of phenytoin exposure.

Conclusions
Cerebellar atrophy may be seen in phenytoin-exposed patients with epilepsy in the absence of generalized tonic-clonic seizures or preexistent brain damage. Whether it is the phenytoin or the seizures that play the primary etiologic role remains unanswered. These factors may be synergistic.



Author Affiliations

From the Departments of Neurology (Drs Ney, Lantos, Barr, and Schaul), Radiology (Dr Lantos), and Psychiatry (Dr Barr), Long Island Jewish Medical Center and Hillside Hospital, Albert Einstein College of Medicine, New Hyde Park, NY.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anticonvulsant Blood Levels: Historical Review With a Pediatric Focus
Snodgrass and Parks
J Child Neurol 2000;15:734-746.
ABSTRACT  

Posterior Fossa Malformations and Epilepsy
Parmeggiani et al.
J Child Neurol 1999;14:113-117.
ABSTRACT  

Cerebellar Atrophy Decreases the Threshold of Carbamazepine Toxicity in Patients With Chronic Focal Epilepsy
Specht et al.
Arch Neurol 1997;54:427-431.
ABSTRACT  

Phenytoin and Cerebellar Atrophy
Theodore
Arch Neurol 1995;52:232-232.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.